Although Celecoxib prolongs survival of the superoxide dismutase 1 (SOD1) G93A mouse model,19 treatment of ALS patients with high Celecoxib dosing did not result in a beneficial clinical outcome or delayed disease progression.20 Here, SOD1 is linked to amyotrophic lateral sclerosis.